Osteoboost in the news

Osteoboost CEO Laura Yecies raised $8M for her FDA-cleared bone density wearable — even as AI dominates venture capital.

Osteoboost raises $8M to expand its FDA-cleared vibration wearable — the only non-drug treatment for bone loss in postmenopausal women.

Osteoboost raises $8M to scale its FDA-cleared vibration therapy wearable targeting osteopenia in postmenopausal women.

Osteoboost raises $8M to scale its FDA-cleared, non-drug wearable for bone density loss in postmenopausal women with osteopenia.

Osteoboost raises $8M to expand its FDA-cleared wearable belt for postmenopausal women with osteopenia — the only non-drug treatment proven to slow bone loss

Osteoboost has secured $8M to expand its FDA-cleared vibration therapy wearable, clinically proven to slow bone density loss in postmenopausal women with...

Not every breakthrough needs AI. Sometimes it’s NASA inspired vibration therapy in a belt. The belt sends targeted vibrations to stimulate bone building cells i

Osteoboost, the FDA-cleared vibrating wearable designed to combat bone density loss, is manufactured in Medford, Oregon.

KTLA covers Osteoboost, the FDA‑cleared wearable belt using vibration therapy to strengthen bones and help prevent osteoporosis in postmenopausal women.

Discover expert tips on maintaining bone health, including the role of innovative therapies like Osteoboost, in this Seattle Times feature.

The Mercury News highlights Osteoboost, a NASA-inspired wearable that reduces bone fracture risk through low-vibration therapy.

CEO Laura Yecies discusses Osteoboost, the FDA-cleared, drug-free wearable combating bone loss in postmenopausal women.